Hot Pursuit     16-Jun-23
Zydus Lifesciences Ltd spurts 0.94%, up for five straight sessions
Zydus Lifesciences Ltd is quoting at Rs 554.3, up 0.94% on the day as on 12:44 IST on the NSE. The stock is up 65.12% in last one year as compared to a 22.6% gain in NIFTY and a 12.1% gain in the Nifty Metal.

Zydus Lifesciences Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 554.3, up 0.94% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.33% on the day, quoting at 18750.45. The Sensex is at 63120.27, up 0.32%. Zydus Lifesciences Ltd has added around 6.84% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has added around 6.72% in last one month and is currently quoting at 13160.6, up 0.54% on the day. The volume in the stock stood at 10.31 lakh shares today, compared to the daily average of 12.97 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 553.95, up 0.58% on the day. Zydus Lifesciences Ltd is up 65.12% in last one year as compared to a 22.6% gain in NIFTY and a 12.1% gain in the Nifty Metal index.

The PE of the stock is 33.04 based on TTM earnings ending March 23.

Previous News
  Zydus Lifesciences receives USFDA approval for Scopolamine Transdermal System
 ( Corporate News - 30-Aug-24   15:12 )
  Barometers end with minor gains; broader mkt outperforms
 ( Market Commentary - Quick Review 18-May-24   12:44 )
  Zydus receives USFDA warning for injectables manufacturing unit at Jarod
 ( Corporate News - 30-Aug-24   14:49 )
  Sensex up 203 pts, oil & gas shares advance
 ( Market Commentary - Mid-Session 24-Apr-24   14:36 )
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Barometers trade higher; Pharma shares advance; Biocon rallies over 3%
 ( Market Commentary - Mid-Session 28-Mar-24   12:32 )
  Zydus Life Jarod facility receives USFDA warning letter
 ( Hot Pursuit - 30-Aug-24   15:11 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Life Q3 PAT climbs 27% YoY to Rs 790 cr; board OKs Rs 600 cr share buyback
 ( Hot Pursuit - 09-Feb-24   14:22 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top